Top-News

Icecure Medical Aktie News

Aktie
WKN:  A1W1LG ISIN:  IL0011224156 US-Symbol:  ICCM Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  Israel
0,6789 $
-0,0278 $
-3,93%
0,5827 € 04.12.25
Depot/Watchlist
Marktkapitalisierung *
34,19 Mio. €
Streubesitz
52,20%
KGV
-
Index-Zuordnung
-

Icecure Medical News

10.03.25 - PR Newswire
Breast Cancer Patients who Underwent IceCure's ProSense® Cryoablation in Japan Reported Significantly Higher Satisfaction than Patients who Underwent Standard of Care Surgery
Breast Cancer Patients who Underwent IceCure's ProSense® Cryoablation in Japan Reported Significantly Higher Satisfaction than Patients who Underwent Standard of Care ...
24.02.25 - PR Newswire
IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense™ Cryoablation System in Israel
IceCure Submits Filing for Regulatory Approval of its Next-​Generation XSense™ Cryoablation System in Israel PR Newswire
04.02.25 - PR Newswire
IceCure's ProSense® in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates FDA's Market Authorization Decision
IceCure's ProSense® in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical ...
27.01.25 - PR Newswire
IceCure Files for Regulatory Approval of ProSense® Cryoablation System in China
IceCure Files for Regulatory Approval of ProSense® Cryoablation System in China PR Newswire
13.01.25 - PR Newswire
IceCure Medical CEO Issues Letter to Shareholders & Reports Increase of 42% in ProSense® Sales for 2024 in North America
IceCure Medical CEO Issues Letter to Shareholders & Reports Increase of 42% in ProSense® Sales for 2024 in North America PR Newswire
06.01.25 - PR Newswire
IceCure Medical Regains Full Nasdaq Compliance with Nasdaq Minimum Closing Bid Price Rule
IceCure Medical Regains Full Nasdaq Compliance with Nasdaq Minimum Closing Bid Price Rule PR Newswire
03.01.25 - PR Newswire
European Patent Office Issues Intention to Grant Notice to IceCure for its Next-Generation Cryoablation Technology
European Patent Office Issues Intention to Grant Notice to IceCure for its Next-​Generation Cryoablation Technology PR Newswire
16.12.24 - PR Newswire
Data on IceCure's ProSense® Cryoablation for Low-Risk Breast Cancer Presented at Radiological Society of North America's 2024 Annual Meeting
Data on IceCure's ProSense® Cryoablation for Low-Risk Breast Cancer Presented at Radiological Society of North America's 2024 Annual Meeting PR Newswire
05.12.24 - PR Newswire
IceCure's ProSense® Cryoablation Safe and Effective in Destruction of Kidney Tumors with 88.7% Recurrence-Free Rate Based on Interim ICESECRET Study Results
IceCure's ProSense® Cryoablation Safe and Effective in Destruction of Kidney Tumors with 88.7% Recurrence-​Free Rate Based on Interim ICESECRET Study Results PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr +1,03%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »